Presented at the Society for Academic Emergency Medicine Annual Meeting, San Francisco, CA, May 2006. This project was funded by the makers of ondansetron. We approached GlaxoSmithKline (GSK) with the idea for the study, and they agreed to provide funding. GSK remained apart from all phases of the project: they did not approve the study design nor participate in data collection, analysis, writing the manuscript, or approval of the final manuscript. ClinicalTrials.gov Registration Identifier NCT 00429832.
Ondansetron versus Promethazine to Treat Acute Undifferentiated Nausea in the Emergency Department: A Randomized, Double-blind, Noninferiority Trial
Version of Record online: 26 FEB 2008
© 2008 by the Society for Academic Emergency Medicine
Academic Emergency Medicine
Volume 15, Issue 3, pages 209–215, March 2008
How to Cite
Braude, D. and Crandall, C. (2008), Ondansetron versus Promethazine to Treat Acute Undifferentiated Nausea in the Emergency Department: A Randomized, Double-blind, Noninferiority Trial. Academic Emergency Medicine, 15: 209–215. doi: 10.1111/j.1553-2712.2008.00060.x
- Issue online: 26 FEB 2008
- Version of Record online: 26 FEB 2008
- Received July 24, 2007; revisions received October 19 and November 4, 2007; accepted December 5, 2007.
- 1Nausea and vomiting management in US emergency departments [abstract]. Acad Emerg Med. 2003; 10:461., , .
- 18U.S. Food and Drug Administration. FDA strengthens warnings for droperidol. FDA Talk Paper. T01–62. December 5, 2001.
- 20PDR Staff. 2007 Drug Topics Red Book. Boston, MA: Thomson Healthcare, 2007.
- 21Measuring pain intensity in the emergency department: correlation of a numeric rating scale with a visual analog scale [abstract]. Acad Emerg Med. 2003; 10:484., , .